RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nichi-Iko Pharmaceutical Co Stock

Nichi-Iko Pharmaceutical Co Stocks 2024

Nichi-Iko Pharmaceutical Co Stocks

67.54 M

Ticker

4541.T

ISIN

JP3687200000

WKN

A0DQVE

In 2024, Nichi-Iko Pharmaceutical Co had 67.54 M outstanding stocks, a 0% change from the 67.54 M stocks in the previous year.

The Nichi-Iko Pharmaceutical Co Stocks history

YEARNUMBER OF STOCKS (undefined JPY)
2027e67.54
2026e67.54
2025e67.54
2024e67.54
2023e67.54
202267.54
202164.02
202064.06
201960.19
201856.46
201757.03
201659.95
201559.86
201444
201351
201252
201150
201041
200940
200840
200740
200637
200536
200436
200337

Nichi-Iko Pharmaceutical Co shares outstanding

The number of shares was Nichi-Iko Pharmaceutical Co in 2023 — This indicates how many shares 67.541 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Nichi-Iko Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Nichi-Iko Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Nichi-Iko Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Nichi-Iko Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Nichi-Iko Pharmaceutical Co Aktienanalyse

What does Nichi-Iko Pharmaceutical Co do?

Nichi-Iko Pharmaceutical Co Ltd is a Japanese company founded in 1965 by Shin-ichi Oka. The company is now one of the largest generic drug manufacturers in Japan and has also made a name for itself in the international market in recent years. Nichi-Iko currently employs about 4800 people and is headquartered in Toyama, Japan. The business model of Nichi-Iko is focused on producing high-quality and cost-effective generic drugs for the global market. The company has an extensive research and development department that continuously develops and improves new products. The goal is to offer a wide range of medicines to meet the needs of patients in different countries. Nichi-Iko has various divisions that the company focuses on. One of the most important divisions is oncology products. Nichi-Iko has a wide range of products for cancer treatment on the market. The company has also expanded into other areas such as infectious diseases, cardiology, neurology, and dermatology. The product range includes tablets, capsules, injection solutions, eye drops, and inhalation products. The company also has an extensive distribution infrastructure that focuses on strengthening its global presence. Nichi-Iko has branches in Japan, the United States, Europe, and Asia. The presence in the global market has helped the company distribute its products in more than 50 countries. Nichi-Iko places a high value on quality control. The company has quality control facilities such as the central laboratory and research and development department. The company takes responsibility for the quality of its products and enables doctors and pharmacists to prescribe safe and effective medicines to their patients. Nichi-Iko also strives for a more sustainable future. The company is committed to promoting environmentally friendly business practices. Nichi-Iko is committed to reducing its energy and water consumption, as well as reducing its waste products. The company has also launched an initiative to promote medication recycling in order to expand the possibilities of using medical waste. In summary, Nichi-Iko Pharmaceutical Co Ltd is a leading generic drug manufacturer focused on producing high-quality and cost-effective medicines. The company has expanded into various areas and operates in the global market. Nichi-Iko places great importance on quality control and is committed to being more environmentally friendly. Nichi-Iko Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Nichi-Iko Pharmaceutical Co's Shares Outstanding

Nichi-Iko Pharmaceutical Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Nichi-Iko Pharmaceutical Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Nichi-Iko Pharmaceutical Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Nichi-Iko Pharmaceutical Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Nichi-Iko Pharmaceutical Co stock

How many stocks are there of Nichi-Iko Pharmaceutical Co?

The current number of stocks of Nichi-Iko Pharmaceutical Co is 67.54 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Nichi-Iko Pharmaceutical Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Nichi-Iko Pharmaceutical Co evolved in recent years?

The number of shares of Nichi-Iko Pharmaceutical Co has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Nichi-Iko Pharmaceutical Co as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Nichi-Iko Pharmaceutical Co?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Nichi-Iko Pharmaceutical Co pay?

Over the past 12 months, Nichi-Iko Pharmaceutical Co paid a dividend of 20 JPY . This corresponds to a dividend yield of about 57.14 %. For the coming 12 months, Nichi-Iko Pharmaceutical Co is expected to pay a dividend of 0 JPY.

What is the dividend yield of Nichi-Iko Pharmaceutical Co?

The current dividend yield of Nichi-Iko Pharmaceutical Co is 57.14 %.

When does Nichi-Iko Pharmaceutical Co pay dividends?

Nichi-Iko Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of Nichi-Iko Pharmaceutical Co?

Nichi-Iko Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Nichi-Iko Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nichi-Iko Pharmaceutical Co located?

Nichi-Iko Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nichi-Iko Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nichi-Iko Pharmaceutical Co from 12/1/2021 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 9/29/2021.

When did Nichi-Iko Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2021.

What was the dividend of Nichi-Iko Pharmaceutical Co in the year 2023?

In the year 2023, Nichi-Iko Pharmaceutical Co distributed 0 JPY as dividends.

In which currency does Nichi-Iko Pharmaceutical Co pay out the dividend?

The dividends of Nichi-Iko Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nichi-Iko Pharmaceutical Co

Our stock analysis for Nichi-Iko Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nichi-Iko Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.